Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF Sept. 3, 2010 Issue | Archived Issues

Drug Substitutions Due to Shortages

Pharmacy Focus

Morphine injection nationwide shortage ...

Bumetanide (Bumex®) 1mg/4ml injection shortage ... 

» Read more


Inpatient Order Status

Web/VS Tip of the Week

Did you know that you can check the status of an inpatient order in Web/VS? The Orders section can be viewed by individual categories or all categories at once.

» Read more


Meetings and Events

High Holiday Services – Sept. 9, 17, 18

Leadership and Life Strategies: A New Mental Diet – Sept. 13

Ethics Noon Conference – Sept. 15

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

Drug Substitutions Due to Shortages

Pharmacy Focus

Morphine Injection Nationwide Shortage

Due to manufacturing delays, there is currently a nationwide shortage of all formulations of morphine injection. It is unclear at this time how long the shortage will continue. However, given that Cedars-Sinai's current supply of morphine injection is critically low, the Pharmacy and Therapeutics and Anesthesiology Chairs have approved an automatic substitution from morphine injection to HYDROmorphone (Dilaudid®) injection at the following ratio: morphine 10mg IV= HYDROmorphone 1.5mg IV.

Please order HYDROmorphone (Dilaudid®) injection for your patients unless they meet the following criteria: neonates, HYDROmorphone allergy, or cardiac patients with chest pain.

Morphine Injection Shortage and Substitution

Bumetanide (Bumex®) 1mg/4ml Injection Shortage

Bumetanide 1mg/4ml injection is also currently on shortage from the manufacturer. However, since bumetanide 2.5mg/10ml injection vials are still available, we are in the process of changing all of our bumetanide stock from 1mg/4ml to 2.5mg/10ml.

Please note that although the vial size will change, the concentration (0.25mg/ml) will remain the same.